Global Pharmaceuticals & Biotech Big Green Snowflakes

Read-Gene

Market Cap: zł71.4m

Engages in the detection, prevention, and treatment of various types of cancer.

Nanologica

Market Cap: SEK 102.1m

A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally.

Galderma Group

Market Cap: CHF 34.5b

Operates as a dermatology company worldwide.

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Oxford Biomedica

Market Cap: UK£712.7m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Biofrontera

Market Cap: US$9.2m

A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Vistagen Therapeutics

Market Cap: US$110.8m

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders.

Azitra

Market Cap: US$2.7m

An early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases.

Abera Bioscience

Market Cap: SEK 114.4m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

C4 Therapeutics

Market Cap: US$190.7m

A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.

Adagene

Market Cap: US$117.8m

A clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers in the People’s Republic of China.

Talphera

Market Cap: US$17.5m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.

Marinomed Biotech

Market Cap: €35.4m

A biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally.

Corbus Pharmaceuticals Holdings

Market Cap: US$116.8m

A biopharmaceutical company, develops products to defeat serious illness.

Gerresheimer

Market Cap: €1.5b

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

NanoSphere Health Sciences

Market Cap: CA$256.9k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

Par Drugs and Chemicals

Market Cap: ₹1.3b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.

Apex Healthcare Berhad

Market Cap: RM 1.7b

An investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally.

TTK Healthcare

Market Cap: ₹16.1b

Engages in the animal welfare, consumer product, medical device, protective device, food, and other businesses in India.

Genetic Signatures

Market Cap: AU$59.1m

Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.

Yung Zip Chemical Ind

Market Cap: NT$906.8m

Yung Zip Chemical Ind. Co., Ltd., manufacturing, trading and sale of pharmaceuticals, pharmaceuticals, agricultural and industrial drugs, APIs, specialty chemicals and other related products internationally.

Aarti Pharmalabs

Market Cap: ₹82.2b

Engages in the manufacture and sale of active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.

InnoCare Pharma

Market Cap: HK$33.4b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Cullinan Therapeutics

Market Cap: US$403.5m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Modalis Therapeutics

Market Cap: JP¥6.6b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

Eurobio Scientific Société anonyme

Market Cap: €253.4m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

4basebio

Market Cap: UK£132.3m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

Alzinova

Market Cap: SEK 133.5m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

Shandong Lukang PharmaceuticalLtd

Market Cap: CN¥8.8b

Operates as a pharmaceutical company in China.

Uni-Bio Science Group

Market Cap: HK$949.4m

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.

PanGen Biotech

Market Cap: ₩83.7b

Operates as a biologics company in South Korea.

Zhuhai Rundu Pharmaceutical

Market Cap: CN¥4.7b

Develops, produces, and markets pharmaceutical ingredients for cardiovascular, gastrointestinal, and CNS worldwide.

Sensei Biotherapeutics

Market Cap: US$10.4m

A clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.

Shield Therapeutics

Market Cap: UK£80.7m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Compass Therapeutics

Market Cap: US$597.1m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

CervoMed

Market Cap: US$92.5m

A a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.